Lisa Smith

Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions

Gerard Lozanski, Nyla A. Heerema, Ian W. Flinn et al. · Blood · 2004 · 403 citations · Full text

Medicine, Oncology, Pharmacology +16

Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia

Neil E. Kay, Susan M. Geyer, Timothy G. Call et al. · Blood · 2006 · 293 citations · Full text

Pharmacy, Immunology, Oncology +14

Epigenetic Profiling in Chronic Lymphocytic Leukemia Reveals Novel Methylation Targets

Laura J. Rush, Aparna Raval, Pauline Funchain et al. · Cancer Research · 2004 · 150 citations · Full text

Life Sciences, Genetics, Oncology +9

Nitrous oxide analgesia for minor pediatric surgical procedures: an effective alternative to conscious sedation?

Cathy A. Burnweit, Jeannette A Diana-Zerpa, Michel Nahmad et al. · Journal of Pediatric Surgery · 2004 · 91 citations

Medicine, Anesthesiology, Surgery +16

Interphase cytogenetic abnormalities in chronic lymphocytic leukemia may predict response to rituximab.

John C. Byrd, Lisa Smith, Marcy L. Hackbarth et al. · PubMed · 2003 · 91 citations

Life Sciences, Hematology, Oncology +14